In observance of World Arthritis Day, the Arthritis Foundation is calling on Americans to “Do Blue” on Tues., Oct. 12. From dressing head to toe with blue (hair) dos to blue shoes – and everything in between – to lighting up national monuments in blue, the effort aims to raise awareness of arthritis in all its forms and to urge the nation and individuals to take action to reduce the impact of the most common cause of disability in the U.S.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/46624/
Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, reported that The New England Journal of Medicine today published results from Cohort B of The PARTNER Trial, which studied the Edwards SAPIEN transcatheter heart valve for the treatment of severe aortic stenosis. The results of the trial successfully met the primary endpoints of all-cause mortality and mortality plus repeat hospitalization.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/44227/
It\\\'s that time of year when you may find yourself feeling that dreaded tingle on you lip that you know will eventually turn into a cold sore. Although cold sores can appear on your lip year round due to cold weather, sun exposure, stress, sickness, injury to the mouth or lack of sleep, outbreaks are most prevalent in the winter time. A new, informative and entertaining website, www.MedicineNotMyth.com helps you identify the right treatments that can help you prevent or shorten an outbreak and understand and avoid cold sore triggers.
http://www.TheLeanYou.com Natural Weight Loss and Wellness with Dr. Dan Giuglianotti. If you feel lost, and frustrated while struggling to get through life and improve your health -- You are not alone! Many of us are stressed, overweight, and have and endless list of things to accomplish, both at work and at home. Despite being a highly trained physician, I was still was confused about how to get lean, be more productive and simply enjoy life. If you're having a hard time shedding those extra pounds and stress, it's for good reason. Dr. Dan Giuglianotti - Physician & Certified Health Fitness Specialist American College of Sports Medicine. http://www.facebook.com/theleanyou http://twitter.com/theleanyou
St. George’s University (SGU) School of Veterinary Medicine, Grenada, West Indies, announced that it has been granted full accreditation by the American Veterinary Medical Association’s (AVMA) Council on Education (COE), the highest standard of achievement for veterinary medical education in the United States.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52545-st-george-s-university-school-of-veterinary-medicine-avma-accreditation
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Sermo, Inc. (www.sermo.com), the largest online network in the United States exclusive to physicians, today introduced Sermo Mobile, an application that allows physicians to access the country’s greatest concentration of medical knowledge in real-time. Sermo Mobile builds on Sermo’s current web platform, an online resource where physicians from across 68 specialties and all 50 states collaborate, discuss and consult with each other to provide the highest quality care to their patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51104-sermo-launches-real-time-medicine-mobile-app-for-physicians
University Hospitals (UH) Case Medical Center has announced a $250 million initiative that promises to dramatically change how drugs will advance from discovery in the laboratories to commercialization, resulting in greater access to advanced treatments and cures for patients. The first-of-its-kind initiative, named The Harrington Project for Discovery & Development, is powered by a $50 million gift – the largest donation in the health system’s history – from the Harrington family, recognized entrepreneurs and philanthropists in Cleveland.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54909-university-hospitals-uh-harrington-discovery-institute-development-project
Heartwarming and laugh out loud funny, In Stitches is a universal coming of age story about a kid who found the best in himself by bringing out the best in others and finally learned to be comfortable in his own skin. It is a refreshing insight into what it takes to become a premiere doctor. Learn about the book here http://bit.ly/In_Stitches_Book Learn about the author here http://bit.ly/InStitches Medicine, biography
A unique 5 step system to beating infertility and getting pregnant the natural way using holistic medicine and ancient Chinese techniques. Visit our website for full information and our extensive list of glowing testimonials from Happy New Mums!
The day when a surgeon can pull a new human vein “off the shelf” for use in life-saving vascular surgeries is now one step closer to reality. New research published in the current issue of the journal Science Translational Medicine demonstrates the efficacy of tissue-engineered vascular grafts (TEVGs) that are immediately available at the time of surgery and have decreased potential for infection, obstruction or clotting. The bioengineering method of producing veins reported in the newly-published research shows promise in both large and small diameter applications, such as for Coronary Artery Bypass Graft (CABG) surgery and for vascular access in hemodialysis.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/humacyte/48336/
